Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
240.24
-7.45 (-3.01%)
Sep 17, 2026, 11:26 AM EDT - Market open
Ascendis Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $344 | Buy | Reiterates | $344 | +43.19% | Sep 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $304 | Buy | Maintains | $304 | +26.54% | Sep 16, 2026 |
| Wedbush | Wedbush | Buy Maintains $327 | Buy | Maintains | $327 | +36.12% | Sep 16, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $319 | Buy | Maintains | $319 | +32.79% | Sep 15, 2026 |
| Raymond James | Raymond James | Buy Maintains $287 | Buy | Maintains | $287 | +19.47% | Sep 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $273 | Buy | Reiterates | $273 | +13.64% | Sep 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $304 → $312 | Buy | Maintains | $304 → $312 | +29.87% | Sep 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.